Prenetics Global Limited (NASDAQ: PRE) (Prenetics or the Company), a leading genomics and precision oncology company, today announced financial results…
Browsing: Prenetics Global Limited
Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a…
Target Price at USD7.00 It is reported that Cantor Fitzgerald initiated coverage on Prenetics Global (PRE.US) with “Overweight” rating and…
Prenetics has completed the majority stake acquisition of ACT Genomics to spearhead its entry into to the US$80+ billion global…
Prenetics will be acquiring a majority stake in ACT Genomics Holdings Company Limited (“ACT”) for an upfront consideration consisting of…
Prenetics Global Limited (NASDAQ: PRE) (Prenetics or the Company), a global leader in genomic and diagnostic testing, today announced that…
Prenetics Global Limited (NASDAQ: PRE) (Prenetics or the Company), a global leader in genomic and diagnostic testing, today announced its…